L. Gogou

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship.

Raffaella Barone, Françoise Borson‐Chazot, Roelf Valkema et al. · PubMed · 2005 · 292 citations · Full text

Pharmacy, Oncology, Pharmacology +17

TPA, TATI, CEA, AFP, β-HCG, PSA, SCC, and CA 19-9 for Monitoring Transitional Cell Carcinoma of the Bladder

Dimitrios Pectasides, D. Bafaloucos, Faye Antoniou et al. · American Journal of Clinical Oncology · 1996 · 65 citations

Medicine, Oncology, Urology +14

Clinical Value of CA 15-3, Mucin-like Carcinoma-Associated Antigen, Tumor Polypeptide Antigen, and Carcinoembryonic Antigen in Monitoring Early Breast Cancer Patients

Dimitrios Pectasides, Nikolaos Pavlidis, L. Gogou et al. · American Journal of Clinical Oncology · 1996 · 28 citations

Medicine, Oncology, Pathology +17

Squamous Cell Carcinoma Antigen, Tumor-Associated Trypsin Inhibitor, and Carcinoembryonic Antigen for Monitoring Cervical Cancer

Dimitrios Pectasides, Nicholas G. Economides, J. Bourazanis et al. · American Journal of Clinical Oncology · 1994 · 26 citations

Medicine, Oncology, Pathology +17

Dosimetric evaluation of the staff working in a PET/CT department

K. Dalianis, Julia Malamitsi, L. Gogou et al. · Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment · 2006 · 19 citations

Medicine, Nuclear Medicine, Radiology +12